Thus, {HEAD ~ the conjugate} of {TAIL ~ the present invention} has one or more improved properties as compared to commercially available rFVIIa, including increased functional in vivo half life and increased plasma half life, and increased bioavailability and reduced sensitivity to proteolytic degradation 
of
Thus , { HEAD ~ the conjugate } of { TAIL ~ the present invention } has one or more improved properties as compared to commercially available rFVIIa , including increased functional in vivo half life and increased plasma half life , and increased bioavailability and reduced sensitivity to proteolytic degradation
OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH